| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| R-(+)-2-(2-呋喃基)-1-甲基吡咯烷甲碘化物 | R-(+)-2-(2-furyl)-1-methylpyrrolidine methiodide | 1039034-03-1 | C10H16NO*I |
| R-(+)-1,1’-联萘-2’-乙基-2-二苯膦 | (S)-(-)-2-(diphenylphosphino)-2'-ethyl-1,1'-binaphthyl | 137769-32-5 | C34H27P |
| R,R,R,(E)3,7,11,15-四甲基-2-十六烯-1-醇乙酸酯 | (R,R,E)-phytyl acetate | 10236-16-5 | C22H42O2 |
| R(-)-丙基去甲阿朴吗啡盐酸盐 | N-propylnorapomorphine | 18426-20-5 | C19H21NO2 |
| R(-)-N-烯丙基去甲阿朴吗啡氢溴酸盐 | (R)-6-Allyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol | 18426-17-0 | C19H19NO2 |
| R(-)-4-氰基-3-羟基丁酸乙酯 | (R)-ethyl 4-cyano-3-hydroxybutyrate | 141942-85-0 | C7H11NO3 |
| R(+)-α-甲基苄胺和(S)-3-(2-噻吩基硫基)丁酸化合物 | D-(+)-methylbenzylamine (3S)-3-(2-thienylthio)butyrate salt | 1197375-23-7 | C8H10O2S2*C8H11N |
| R(+)-3-氨基-1-羟基-2-吡咯烷酮 | (3R)-3-amino-1-hydroxypyrrolidin-2-one | 123931-04-4 | C4H8N2O2 |
| Quin2钾盐水合物 | —— | 149022-19-5 | C26H29KN3O11 |
| Ptm-88合金 | —— | 105038-79-7 | CoGa2Pd22 |
| Psi,Psi-胡罗卜素-16,16'-二醇 | 16,16'-dihydroxylycopene | 19891-75-9 | C40H56O2 |
| Pmc-S-甲基异硫脲 | methyl N-[(2,2,5,7,8-pentamethyl-3,4-dihydro-2H-chromen-6-yl)sulfonyl]imidothiocarbamate | 185674-98-0 | C16H24N2O3S2 |
| Pleconaril-d8(主要) | Pleconaril-d8 (Major) | 1346602-36-5 | C18H18F3N3O3 |
| Pgc钯合金 | —— | 107373-32-0 | Au2Ca10Ga10Pd76 |
| Per氟苯基3-(2-(2-叠氮基乙氧基)乙氧基)丙酸酯 | perfluorophenyl 3-(2-(2-azidoethoxy)ethoxy)propanoate | 1393330-37-4 | C13H12F5N3O4 |
| Paull酮 | paullone | 142273-18-5 | C16H12N2O |
| PY-2H-四嗪-PY-NHBOC | 2-(Boc-amino)-N-(6-(6-(pyridin-2-yl)-1,4-dihydro-1,2,4,5-tetrazin-3-yl)pyridin-3-yl)acetamide | 1360467-39-5 | C19H22N8O3 |
| PX20606 反式异构体 | PX-20606 | 1268244-85-4 | C29H22Cl3NO4 |
| PVM/MA共聚物 | vorasidenib | 1644545-52-7 | C14H13ClF6N6 |
| PROTOPORPHYRIN營XCOBALTCHLORIDE | Co(iii) protoporphyrin ix chloride | 102601-60-5 | C34H32ClCoN4O4 |
| PPG-2肉豆蔻醇醚丙酸酯 | PPG-2 myristyl ether propionate | 111497-87-1 | C23H46O4 |
| PPG-2甲醚 | Dipropylenglykol-monomethylether | 13429-07-7 | C7H16O3 |
| PPADS四钠盐 | Ppads | 149017-66-3 | C14H14N3O12PS2 |
| POSS-十二苯基 | Heptacyclo(11.11.1.13,9.15,21.17,19.111,17.115,23)dodecasiloxane, 1,3,5,7,9,11,13,15,17,19,21,23-dodecaphenyl- | 18923-59-6 | C72H60O18Si12 |
| PORCN酶活性和WNT抑制剂(WNT-C59) | 2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide | 1243243-89-1 | C25H21N3O |
| PND-1186游离态 | 2-(2-(2-methoxy-4-morpholinophenylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N-methylbenzamide | 1061353-68-1 | C25H26F3N5O3 |
| PNA-胸腺嘧啶单体 | 2-(N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamido)acetic acid | 169396-92-3 | C26H26N4O7 |
| PNA-胞嘧啶单体 | N-(N-Fmoc-2-aminoethyl)-N-[(N-4-Bhoc-1-cytosyl)acetyl]glycine | 186046-81-1 | C39H35N5O8 |
| PLK1抑制剂(RO3280) | RO3280 | 1062243-51-9 | C27H35F2N7O3 |
| PKR抑制剂(MITAPIVAT) | N-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide | 1260075-17-9 | C24H26N4O3S |
| PKI-402; 1-[4-[3-乙基-7-(吗啉-4-基)-3H-[1,2,3]三唑并[4,5-d]嘧啶-5-基]苯基]-3-[4-[(4-甲基哌嗪-1-基)羰基]苯基]脲 | PKI-402 | 1173204-81-3 | C29H34N10O3 |
| PKD抑制剂(CRT0066101DIHYDROCHLORIDE) | CRT0066101 Dihydrochloride | 1883545-60-5 | C18H24Cl2N6O |
| PIERS-GRUBBS第一代催化剂 | Dichloro(PCy3)[(tricyclohexylphosphoranyl)methylidene]Ru tetrafluoroborate | 1020085-61-3 | BF4*C37H67Cl2P2Ru |
| PI3K纬INHIBITOR1 | PI3Kgamma inhibitor 1 | 1172118-03-4 | C32H26N8O2S |
| PI3K抑制剂(GDC-0032) | taselisib | 1282512-48-4 | C24H28N8O2 |
| PI3K伪/MTOR-IN-1 | 2-amino-8-cyclopentyl-6-(1H-pyrazol-4-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one | 1013098-90-2 | C16H18N6O |
| PI3Kα抑制剂1 | N-hydroxy-2-(methyl((2-(6-(methylamino)pyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)amino)pyrimidine-5-carboxamide | 1235449-52-1 | C23H25N9O3S |
| PHT 427; 4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺 | ARC-183 | 1191951-57-1 | C20H31N3O2S2 |
| PHENYLMETHYL2-DEOXY-3,6-BIS-O-(PHENYLMETHYL)-2-[[(2,2,2-TRICHLOROETHOXY)CARBONYL]AMINO]-Β-D-GLUCOPYRANOSIDE苯基甲基2-脱氧-3,6-双-O-(苯基甲基)-2-[[(2,2,2-三氯乙氧基)羰基]氨基]-Β-D-吡喃葡萄糖苷 | 2,2,2-Trichloroethyl ((2R,3R,4R,5S,6R)-2,4-bis(benzyloxy)-6-((benzyloxy)methyl)-5-hydroxytetrahydro-2H-pyran-3-yl)carbamate | 1401413-17-9 | C30H32Cl3NO7 |
| PFK158游离 | PFK158 | 1462249-75-7 | C18H11F3N2O |
| PF06463922中间体 | 1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrile hydrochloride | 1643141-20-1 | C7H10N4*ClH |
| PF-38414 | PF-3084014 | 1290543-63-3 | C27H41F2N5O |
| PF-06700841甲苯磺酸盐 | brepocitinib | 1883299-62-4 | C18H21F2N7O |
| PF-06305591二水合物 | (2R,3S)-3-amino-3-(5-tert-butyl-1H-benzimidazol-2-yl)-2-methylpropanamide | 1449473-97-5 | C15H22N4O |
| PF-04965842(阿布罗替尼) | abrocitinib | 1622902-68-4 | C14H21N5O2S |
| PF-04620110; 反式-4-[4-(4-氨基-7,8-二氢-5-氧代嘧啶并[5,4-f][1,4]氧氮杂卓-6(5H)-基)苯基]环己烷乙酸 | PF-04620110 | 1109276-89-2 | C21H24N4O4 |
| PF 8380; 4-[3-氧代-3-(2-氧代-2,3-二氢苯并恶唑-6-基)丙基]哌嗪-1-羧酸 3,5-二氯苄酯 | 3,5-dichlorobenzyl 4-(3-oxo-3-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)propyl)piperazine-1-carboxylate | 1144035-53-9 | C22H21Cl2N3O5 |
| PF 4942847; 2-氨基-4-[2,4-二氯-6-[2-(1H-吡唑-1-基)乙氧基]苯基]-5,7-二氢-N-(2,2,2-三氟乙基)-6H-吡咯并[3,4-d]嘧啶-6-甲酰胺 | 2-amino-4-[2,4-dichloro-6-(2-(pyrazol-1-yl)ethoxy)phenyl]-5,7-dihydropyrrolo[3,4-d]pyrimidine-6-carboxylic acid (2,2,2-trifluoroethyl)amide | 1046859-34-0 | C20H18Cl2F3N7O2 |
| PET胶水 | N-[4-(4,6-Dimethyl-pyrimidin-2-ylsulfamoyl)-phenyl]-acetamide | 100-90-3 | C14H16N4O3S |
| PEO-四臂-SG封端 | 5-O-(2,5-dioxopyrrolidin-1-yl) 1-O-[2-[5-(2,5-dioxopyrrolidin-1-yl)oxy-5-oxopentanoyl]oxyethyl] pentanedioate | 154467-38-6 | C20H24N2O12 |